Study: NCT03233139

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: Patients will be administered cemiplimab as per protocol. For Cohort A Only, patients with confirmed progressive disease may opt to receive up to 4 cycles of platinum doublet chemotherapy in addition to cemiplimab per investigator's judgement.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: Patients will be administered cemiplimab as per protocol. For Cohort A Only, patients with confirmed progressive disease may opt to receive up to 4 cycles of platinum doublet chemotherapy in addition to cemiplimab per investigator's judgement.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: Patients will be administered cemiplimab as per protocol. For Cohort A Only, patients with confirmed progressive disease may opt to receive up to 4 cycles of platinum doublet chemotherapy in addition to cemiplimab per investigator's judgement.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: Patients will be administered cemiplimab as per protocol. For Cohort A Only, patients with confirmed progressive disease may opt to receive up to 4 cycles of platinum doublet chemotherapy in addition to cemiplimab per investigator's judgement.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: Patients will be administered cemiplimab as per protocol. For Cohort A Only, patients with confirmed progressive disease may opt to receive up to 4 cycles of platinum doublet chemotherapy in addition to cemiplimab per investigator's judgement.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: Patients will be administered cemiplimab as per protocol. For Cohort A Only, patients with confirmed progressive disease may opt to receive up to 4 cycles of platinum doublet chemotherapy in addition to cemiplimab per investigator's judgement.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: To be administered per protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Platinum-doublet chemotherapy
Description: To be administered per protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Platinum-doublet chemotherapy
Description: To be administered per protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Platinum-doublet chemotherapy
Description: To be administered per protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: To be administered per protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: To be administered per protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: To be administered per protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: To be administered per protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: To be administered per protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: To be administered per protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: To be administered per protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fianlimab
Description: To be administered per protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fianlimab
Description: To be administered per protocol